Patients Access solutions: the missing link that prevents biopharma i... We live in unprecedented times, where innovation in biosciences continues to accelerate.
Pharma Market Access Access solutions: the missing link that prevents biopharma i... We live in unprecedented times, where innovation in biosciences continues to accelerate.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
